| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing efmoroctocog alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Efmoroctocog alfa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Efmoroctocog alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing only efmoroctocog alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 1500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 1500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 2000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 2000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 3000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 3000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely efmoroctocog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Efmoroctocog alfa (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]